The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Axon growth inhibition by RhoA/ROCK in the central nervous system
Open accessAbstract
Rho kinase (ROCK) is a serine/threonine kinase and a downstream target of the small GTPase Rho. The RhoA/ROCK pathway is associated with various neuronal functions such as migration, dendrite development, and axonal extension. Evidence from animal studies reveals that RhoA/ROCK signaling is involved in various central nervous system (CNS) diseases, including optic nerve and spinal cord injuries, stroke, and neurodegenerative diseases. Given that RhoA/ROCK plays a critical role in the pathophysiology of CNS diseases, the development of therapeutic agents targeting this pathway is expected to contribute to the treatment of CNS diseases. The RhoA/ROCK pathway mediates the effects of myelin-associated axon growth inhibitors-Nogo, myelin-associated glycoprotein (MAG), oligodendrocyte-myelin glycoprotein (OMgp), and repulsive guidance molecule (RGM). Blocking RhoA/ROCK signaling can reverse the inhibitory effects of these molecules on axon outgrowth, and promotes axonal sprouting and functional recovery in animal models of CNS injury. To date, several RhoA/ROCK inhibitors have been under development or in clinical trials as therapeutic agents for neurological disorders. In this review, we focus on the RhoA/ROCK signaling pathway in neurological disorders. We also discuss the potential therapeutic approaches of RhoA/ROCK inhibitors for various neurological disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
RHO GTPASES: Biochemistry and Biology
Jaffe, A. B., & Hall, A. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.020604.150721 · Cited by 3,009
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension
Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T., Morishita, T., Tamakawa, H., Yamagami, K., Inui, J., Maekawa, M., et al. (1997) · Nature · doi:10.1038/40187 · Cited by 2,859
ROCKs: multifunctional kinases in cell behaviour
Riento, K., & Ridley, A. J. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1128 · Cited by 1,941
Antigen Presentation and T Cell Stimulation by Dendritic Cells
Guermonprez, P., Valladeau, J., Zitvogel, L., Théry, C., & Amigorena, S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064828 · Cited by 1,926
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724 · cited 2×
“The immune system plays a key role in the pathogenesis of MS (Noseworthy et al., 2000; Hauser and Oksenberg, 2006; Trapp and Nave, 2008; Krumbholz and Meinl, 2014).”
BackgroundGlial inhibition of CNS axon regeneration
Yiu, G., & He, Z. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1956 · Cited by 1,495
Chen, M. S., Huber, A. B., van der Haar, M. E., Frank, M., Schnell, L., Spillmann, A. A., Christ, F., & Schwab, M. E. (2000) · Nature · doi:10.1038/35000219 · Cited by 1,445
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · cited 3×
“Intracerebral or Intrathecal administration of neutralizing antibodies for Nogo (designated as IN-1), implantation of IN-1 mAb-secreting hybridoma cells (Schnell and Schwab, 1990; Bregman et al., 1995; Brosamle et al., 2000; Merkler et al., 2001), or NgR antagonist peptide NEP1-40 (Nogo extracellular peptide, residues…”
BackgroundMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · cited 1×
“Some non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to reduce the risk of AD development (McGeer et al., 1996; Anthony et al., 2000; Weggen et al., 2001; Eriksen et al., 2003).”
BackgroundSchnell, L., & Schwab, M. E. (1990) · Nature · doi:10.1038/343269a0 · Cited by 1,222
Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein
GrandPré, T., Nakamura, F., Vartanian, T., & Strittmatter, S. M. (2000) · Nature · doi:10.1038/35000226 · Cited by 1,139
McKerracher, L., David, S., Jackson, D. L., Kottis, V., Dunn, R. J., & Braun, P. E. (1994) · Neuron · doi:10.1016/0896-6273(94)90247-x · Cited by 1,126
Degeneration and regeneration of axons in the lesioned spinal cord
Schwab, M. E., & Bartholdi, D. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.2.319 · Cited by 1,118
Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration
Fournier, A. E., GrandPre, T., & Strittmatter, S. M. (2001) · Nature · doi:10.1038/35053072 · Cited by 1,080
A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration
Mukhopadhyay, G., Doherty, P., Walsh, F. S., Crocker, P. R., & Filbin, M. T. (1994) · Neuron · doi:10.1016/0896-6273(94)90042-6 · Cited by 1,061
Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth
Wang, K. C., Koprivica, V., Kim, J. A., Sivasankaran, R., Guo, Y., Neve, R. L., & He, Z. (2002) · Nature · doi:10.1038/nature00867 · Cited by 955
Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
Ishizaki, T., Uehata, M., Tamechika, I., Keel, J., Nonomura, K., Maekawa, M., & Narumiya, S. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26508-1 · Cited by 928
Evidence that β-Amyloid Protein in Alzheimer's Disease Is Not Derived by Normal Processing
Sisodia, S. S., Koo, E. H., Beyreuther, K., Unterbeck, A., & Price, D. L. (1990) · Science · doi:10.1126/science.1691865 · Cited by 893
Caroni, P., & Schwab, M. E. (1988) · Neuron · doi:10.1016/0896-6273(88)90212-7 · Cited by 884
Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS
Filbin, M. T. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1195 · Cited by 871
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex
Mi, S., Lee, X., Shao, Z., Thill, G., Ji, B., Relton, J., Levesque, M., Allaire, N., Perrin, S., Sands, B., et al. (2004) · Nature Neuroscience · doi:10.1038/nn1188 · Cited by 826
p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp
Wang, K. C., Kim, J. A., Sivasankaran, R., Segal, R., & He, Z. (2002) · Nature · doi:10.1038/nature01176 · Cited by 819
Nakagawa, O., Fujisawa, K., Ishizaki, T., Saito, Y., Nakao, K., & Narumiya, S. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00811-3 · Cited by 802
The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
Hauser, S. L., & Oksenberg, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 776
CRMP-2 binds to tubulin heterodimers to promote microtubule assembly
Fukata, Y., Itoh, T. J., Kimura, T., Ménager, C., Nishimura, T., Shiromizu, T., Watanabe, H., Inagaki, N., Iwamatsu, A., Hotani, H., et al. (2002) · Nature Cell Biology · doi:10.1038/ncb825 · Cited by 761
Rho Signaling Pathway Targeted to Promote Spinal Cord Repair
Dergham, P., Ellezam, B., Essagian, C., Avedissian, H., Lubell, W. D., & McKerracher, L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06570.2002 · Cited by 726
Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors
Bregman, B. S., Kunkel-Bagden, E., Schnell, L., Dai, H. N., Gao, D., & Schwab, M. E. (1995) · Nature · doi:10.1038/378498a0 · Cited by 716
Nogo-66 receptor antagonist peptide promotes axonal regeneration
GrandPré, T., Li, S., & Strittmatter, S. M. (2002) · Nature · doi:10.1038/417547a · Cited by 711
PTPσ Is a Receptor for Chondroitin Sulfate Proteoglycan, an Inhibitor of Neural Regeneration
Shen, Y., Tenney, A. P., Busch, S. A., Horn, K. P., Cuascut, F. X., Liu, K., He, Z., Silver, J., & Flanagan, J. G. (2009) · Science · doi:10.1126/science.1178310 · Cited by 682
Rho Kinase Inhibition Enhances Axonal Regeneration in the Injured CNS
Fournier, A. E., Takizawa, B. T., & Strittmatter, S. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01416.2003 · Cited by 644
Experience-driven plasticity of visual cortex limited by myelin and nogo receptor
McGee, A. W., Yang, Y., Fischer, Q. S., Daw, N. W., & Strittmatter, S. M. (2005) · Science · doi:10.1126/science.1114362 · Cited by 643
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18162 · Cited by 634 · cited 1×
“Some non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to reduce the risk of AD development (McGeer et al., 1996; Anthony et al., 2000; Weggen et al., 2001; Eriksen et al., 2003).”
BackgroundRho kinase, a promising drug target for neurological disorders
Mueller, B. K., Mack, H., & Teusch, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1719 · Cited by 608
Myelin-Associated Glycoprotein Interacts with the Nogo66 Receptor to Inhibit Neurite Outgrowth
Domeniconi, M., Cao, Z., Spencer, T., Sivasankaran, R., Wang, K. C., Nikulina, E., Kimura, N., Cai, H., Deng, K., Gao, Y., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00770-5 · Cited by 593
Inactivation of Rho Signaling Pathway Promotes CNS Axon Regeneration
Lehmann, M., Fournier, A., Selles-Navarro, I., Dergham, P., Sebok, A., Leclerc, N., Tigyi, G., & McKerracher, L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07537.1999 · Cited by 590
Myelin-Associated Glycoprotein as a Functional Ligand for the Nogo-66 Receptor
Liu, B. P., Fournier, A., GrandPré, T., & Strittmatter, S. M. (2002) · Science · doi:10.1126/science.1073031 · Cited by 577
Inhibitor of neurite outgrowth in humans
Prinjha, R., Moore, S. E., Vinson, M., Blake, S., Morrow, R., Christie, G., Michalovich, D., Simmons, D. L., & Walsh, F. S. (2000) · Nature · doi:10.1038/35000287 · Cited by 559
Jones, L. L., Margolis, R. U., & Tuszynski, M. H. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00087-6 · Cited by 545
CRMP-2 induces axons in cultured hippocampal neurons
Inagaki, N., Chihara, K., Arimura, N., Ménager, C., Kawano, Y., Matsuo, N., Nishimura, T., Amano, M., & Kaibuchi, K. (2001) · Nature Neuroscience · doi:10.1038/90476 · Cited by 543
Neuronal Cyclic AMP Controls the Developmental Loss in Ability of Axons to Regenerate
Cai, D., Qiu, J., Cao, Z., McAtee, M., Bregman, B. S., & Filbin, M. T. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-13-04731.2001 · Cited by 539
Ohashi, K., Nagata, K., Maekawa, M., Ishizaki, T., Narumiya, S., & Mizuno, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3577 · Cited by 533
PirB is a Functional Receptor for Myelin Inhibitors of Axonal Regeneration
Atwal, J. K., Pinkston-Gosse, J., Syken, J., Stawicki, S., Wu, Y., Shatz, C., & Tessier-Lavigne, M. (2008) · Science · doi:10.1126/science.1161151 · Cited by 502
McKeon, R. J., Jurynec, M. J., & Buck, C. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10778.1999 · Cited by 480
Steeves, J. D., Lammertse, D., Curt, A., Fawcett, J. W., Tuszynski, M. H., Ditunno, J. F., Ellaway, P. H., Fehlings, M. G., Guest, J. D., Kleitman, N., et al. (2007) · Spinal Cord · doi:10.1038/sj.sc.3102008 · Cited by 470
The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI
Yamashita, T., & Tohyama, M. (2003) · Nature Neuroscience · doi:10.1038/nn1045 · Cited by 460
Self-citationA p75NTR and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein
Wong, S. T., Henley, J. R., Kanning, K. C., Huang, K.-H., Bothwell, M., & Poo, M.-M. (2002) · Nature Neuroscience · doi:10.1038/nn975 · Cited by 460
Patterns of Nogo mRNA and Protein Expression in the Developing and Adult Rat and After CNS Lesions
Huber, A. B., Weinmann, O., Brösamle, C., Oertle, T., & Schwab, M. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03553.2002 · Cited by 455
NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans
Dickendesher, T. L., Baldwin, K. T., Mironova, Y. A., Koriyama, Y., Raiker, S. J., Askew, K. L., Wood, A., Geoffroy, C. G., Zheng, B., Liepmann, C. D., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3070 · Cited by 449 · cited 1×
“NgR1 and NgR3 bind to CSPG, and mediate the inhibitory effect of CSPG in cultured neurons (Dickendesher et al., 2012).”
BackgroundAxon Regeneration in Young Adult Mice Lacking Nogo-A/B
Kim, J.-E., Li, S., GrandPré, T., Qiu, D., & Strittmatter, S. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00147-8 · Cited by 413
Simonen, M., Pedersen, V., Weinmann, O., Schnell, L., Buss, A., Ledermann, B., Christ, F., Sansig, G., van der Putten, H., & Schwab, M. E. (2003) · Neuron · doi:10.1016/s0896-6273(03)00226-5 · Cited by 401
Monnier, P. P., Sierra, A., Schwab, J. M., Henke-Fahle, S., & Mueller, B. K. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(02)00035-0 · Cited by 400
Dubreuil, C. I., Winton, M. J., & McKerracher, L. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200301080 · Cited by 397
The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho
Yamashita, T., Higuchi, H., & Tohyama, M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200202010 · Cited by 391
Self-citationTang, X., Davies, J. E., & Davies, S. J. A. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10523 · Cited by 386
Lack of Enhanced Spinal Regeneration in Nogo-Deficient Mice
Zheng, B., Ho, C., Li, S., Keirstead, H., Steward, O., & Tessier-Lavigne, M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00225-3 · Cited by 379
Inhibition of Rho Kinase (ROCK) Leads to Increased Cerebral Blood Flow and Stroke Protection
Rikitake, Y., Kim, H.-H., Huang, Z., Seto, M., Yano, K., Asano, T., Moskowitz, M. A., & Liao, J. K. (2005) · Stroke · doi:10.1161/01.str.0000181077.84981.11 · Cited by 375
Localization of Nogo-A and Nogo-66 Receptor Proteins at Sites of Axon–Myelin and Synaptic Contact
Wang, X., Chun, S.-J., Treloar, H., Vartanian, T., Greer, C. A., & Strittmatter, S. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05505.2002 · Cited by 351
Kim, J.-E., Liu, B. P., Park, J. H., & Strittmatter, S. M. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.015 · Cited by 351
PirB restricts ocular-dominance plasticity in visual cortex
Syken, J., GrandPre, T., Kanold, P. O., & Shatz, C. J. (2006) · Science · doi:10.1126/science.1128232 · Cited by 340
Nogo Receptor Antagonism Promotes Stroke Recovery by Enhancing Axonal Plasticity
Lee, J.-K., Kim, J.-E., Sivula, M., & Strittmatter, S. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1643-04.2004 · Cited by 338
Merkler, D., Metz, G. A. S., Raineteau, O., Dietz, V., Schwab, M. E., & Fouad, K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03665.2001 · Cited by 330
Sumi, T., Matsumoto, K., & Nakamura, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007074200 · Cited by 326
Myelin‐associated glycoprotein (MAG): past, present and beyond
Quarles, R. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04319.x · Cited by 326
Nonsteroidal Anti-Inflammatory Drugs Can Lower Amyloidogenic Aß 42 by Inhibiting Rho
Zhou, Y., Su, Y., Li, B., Liu, F., Ryder, J. W., Wu, X., Gonzalez-DeWhitt, P. A., Gelfanova, V., Hale, J. E., May, P. C., et al. (2003) · Science · doi:10.1126/science.1090154 · Cited by 316 · cited 1×
“Inhibition of ROCK by Y-27632 reduced the level of Aβ1–42, which is more prone to aggregation than Aβ1–40 in AD model mice (Zhou et al., 2003).”
BackgroundFisher, D., Xing, B., Dill, J., Li, H., Hoang, H. H., Zhao, Z., Yang, X.-L., Bachoo, R., Cannon, S., Longo, F. M., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1737-11.2011 · Cited by 312 · cited 1×
“Genetic deletion of PTPσ enhances axon sprouting to the regions containing CSPGs in the animal model of SCI. Leukocyte common antigen-related phosphatase (LAR), which is another member in the LAR subfamily of PTPσ, is also identified as a CSPG receptor (Fisher et al., 2011).”
BackgroundAssessing Spinal Axon Regeneration and Sprouting in Nogo-, MAG-, and OMgp-Deficient Mice
Lee, J. K., Geoffroy, C. G., Chan, A. F., Tolentino, K. E., Crawford, M. J., Leal, M. A., Kang, B., & Zheng, B. (2010) · Neuron · doi:10.1016/j.neuron.2010.05.002 · Cited by 312
George, R., & Griffin, J. W. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1164 · Cited by 309
Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth
Benson, M. D., Romero, M. I., Lush, M. E., Lu, Q. R., Henkemeyer, M., & Parada, L. F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504021102 · Cited by 305
Delayed Systemic Nogo-66 Receptor Antagonist Promotes Recovery from Spinal Cord Injury
Li, S., & Strittmatter, S. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04219.2003 · Cited by 305
Moreau-Fauvarque, C., Kumanogoh, A., Camand, E., Jaillard, C., Barbin, G., Boquet, I., Love, C., Jones, E. Y., Kikutani, H., Lubetzki, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09229.2003 · Cited by 293
RGMa inhibition promotes axonal growth and recovery after spinal cord injury
Hata, K., Fujitani, M., Yasuda, Y., Doya, H., Saito, T., Yamagishi, S., Mueller, B. K., & Yamashita, T. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200508143 · Cited by 289
Self-citationNeuroprotection mediated by changes in the endothelial actin cytoskeleton
Laufs, U., Endres, M., Stagliano, N., Amin-Hanjani, S., Chui, D.-S., Yang, S.-X., Simoncini, T., Yamada, M., Rabkin, E., Allen, P. G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9639 · Cited by 282
A Phase I/IIa Clinical Trial of a Recombinant Rho Protein Antagonist in Acute Spinal Cord Injury
Fehlings, M. G., Theodore, N., Harrop, J., Maurais, G., Kuntz, C., Shaffrey, C. I., Kwon, B. K., Chapman, J., Yee, A., Tighe, A., et al. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2011.1765 · Cited by 281
Fischer, D., Petkova, V., Thanos, S., & Benowitz, L. I. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2774-04.2004 · Cited by 275
Zheng, B., Atwal, J., Ho, C., Case, L., He, X.-L., Garcia, K. C., Steward, O., & Tessier-Lavigne, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409026102 · Cited by 269
The role of antigen presenting cells in multiple sclerosis
Chastain, E. M. L., Duncan, D. S., Rodgers, J. M., & Miller, S. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.008 · Cited by 266
Oligodendrocyte‐myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth
Kottis, V., Thibault, P., Mikol, D., Xiao, Z., Zhang, R., Dergham, P., & Braun, P. E. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01146.x · Cited by 264
Rho-kinase as a Novel Therapeutic Target in Treatment of Cardiovascular Diseases
Shimokawa, H. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200203000-00001 · Cited by 262
Cafferty, W. B. J., Duffy, P., Huebner, E., & Strittmatter, S. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6239-09.2010 · Cited by 253
Bartsch, U., Bandtlow, C. E., Schnell, L., Bartsch, S., Spillmann, A. A., Rubin, B. P., Hillenbrand, R., Schwab, D. M. E., & Schachner, M. (1995) · Neuron · doi:10.1016/0896-6273(95)90015-2 · Cited by 250
Lingor, P., Tönges, L., Pieper, N., Bermel, C., Barski, E., Planchamp, V., & Bähr, M. (2008) · Brain · doi:10.1093/brain/awm284 · Cited by 246
Sasaki, Y., Suzuki, M., & Hidaka, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00191-2 · Cited by 234
Brösamle, C., Huber, A. B., Fiedler, M., Skerra, A., & Schwab, M. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-21-08061.2000 · Cited by 233
Venkatesh, K., Chivatakarn, O., Lee, H., Joshi, P. S., Kantor, D. B., Newman, B. A., Mage, R., Rader, C., & Giger, R. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4464-04.2005 · Cited by 227
Greenwood, J., Walters, C. E., Pryce, G., Kanuga, N., Bemud, E., Baker, D., & Adamson, P. (2003) · The FASEB Journal · doi:10.1096/fj.02-1014fje · Cited by 227
Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: The Cache County Study
Anthony, J. C., Breitner, J. C. S., Zandi, P. P., Meyer, M. R., Jurasova, I., Norton, M. C., & Stone, S. V. (2000) · Neurology · doi:10.1212/wnl.54.11.2066 · Cited by 224
Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins
Barton, W. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg325 · Cited by 220
THE NOGO SIGNALING PATHWAY FOR REGENERATION BLOCK
He, Z., & Koprivica, V. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144340 · Cited by 215
Lingor, P., Teusch, N., Schwarz, K., Mueller, R., Mack, H., Bähr, M., & Mueller, B. K. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04756.x · Cited by 214 · cited 1×
“Intravitreous injections of ROCK inhibitors, including Y-27632 and dimethyl-fasudil also improve optic nerve regeneration (Lingor et al., 2007, 2008).”
BackgroundSuppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates
Borisoff, J. F., Chan, C. C. M., Hiebert, G. W., Oschipok, L., Robertson, G. S., Zamboni, R., Steeves, J. D., & Tetzlaff, W. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(02)00032-5 · Cited by 210
Wiessner, C., Bareyre, F. M., Allegrini, P. R., Mir, A. K., Frentzel, S., Zurini, M., Schnell, L., Oertle, T., & Schwab, M. E. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200302000-00003 · Cited by 209
DeBellard, M.-E., Tang, S., Mukhopadhyay, G., Shen, Y.-J., & Filbin, M. T. (1996) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1996.0007 · Cited by 191
Tompkins, S. M., Padilla, J., Dal Canto, M. C., Ting, J. P.-Y., Van Kaer, L., & Miller, S. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.4173 · Cited by 190
Recombinant myelin-associated glycoprotein confers neural adhesion and neurite outgrowth function
Johnson, P. W., Abramow-Newerly, W., Seilheimer, B., Sadoul, R., Tropak, M. B., Arquint, M., Dunn, R. J., Schachner, M., & Roder, J. C. (1989) · Neuron · doi:10.1016/0896-6273(89)90262-6 · Cited by 190
Hendriks, J. J. A., Alblas, J., van der Pol, S. M. A., van Tol, E. A. F., Dijkstra, C. D., & de Vries, H. E. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040819 · Cited by 190
Bertrand, J., Winton, M. J., Rodriguez-Hernandez, N., Campenot, R. B., & McKerracher, L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3931-04.2005 · Cited by 180
Takahashi, Y., Hayashi, I., Tominari, Y., Rikimaru, K., Morohashi, Y., Kan, T., Natsugari, H., Fukuyama, T., Tomita, T., & Iwatsubo, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301619200 · Cited by 179
Tokushige, H., Inatani, M., Nemoto, S., Sakaki, H., Katayama, K., Uehata, M., & Tanihara, H. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1617 · Cited by 177
Beher, D., Clarke, E. E., Wrigley, J. D. J., Martin, A. C. L., Nadin, A., Churcher, I., & Shearman, M. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404937200 · Cited by 177
Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model
Bowerman, M., Beauvais, A., Anderson, C. L., & Kothary, R. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq021 · Cited by 177
Tonges, L., Frank, T., Tatenhorst, L., Saal, K. A., Koch, J. C., Szego, E. M., Bahr, M., Weishaupt, J. H., & Lingor, P. (2012) · Brain · doi:10.1093/brain/aws254 · Cited by 176
The Sphingolipid Receptor S1PR2 Is a Receptor for Nogo-A Repressing Synaptic Plasticity
Kempf, A., Tews, B., Arzt, M. E., Weinmann, O., Obermair, F. J., Pernet, V., Zagrebelsky, M., Delekate, A., Iobbi, C., Zemmar, A., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001763 · Cited by 175
Endo, T., Spenger, C., Tominaga, T., Brené, S., & Olson, L. (2007) · Brain · doi:10.1093/brain/awm237 · Cited by 172
Phosphorylation of profilin by ROCK1 regulates polyglutamine aggregation
Shao, J., Welch, W. J., DiProspero, N. A., & Diamond, M. I. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00079-08 · Cited by 171
Griffin, J. W., George, R., Lobato, C., Tyor, W. R., Li, C. Y., & Glass, J. D. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90129-9 · Cited by 170
Paired immunoglobulin‐like receptors and their MHC class I recognition
Takai, T. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02177.x · Cited by 167
Lee, H., Raiker, S. J., Venkatesh, K., Geary, R., Robak, L. A., Zhang, Y., Yeh, H. H., Shrager, P., & Giger, R. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5586-07.2008 · Cited by 164
Nogo-A-Deficient Mice Reveal Strain-Dependent Differences in Axonal Regeneration
Dimou, L., Schnell, L., Montani, L., Duncan, C., Simonen, M., Schneider, R., Liebscher, T., Gullo, M., & Schwab, M. E. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1103-06.2006 · Cited by 162
Satoh, S.-I., Utsunomiya, T., Tsurui, K., Kobayashi, T., Ikegaki, I., Sasaki, Y., & Asano, T. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01229-2 · Cited by 161
The Nogo Receptor Family Restricts Synapse Number in the Developing Hippocampus
Wills, Z. P., Mandel‐Brehm, C., Mardinly, A. R., McCord, A. E., Giger, R. J., & Greenberg, M. E. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.029 · Cited by 159
Hsieh, S. H. ‐., Ferraro, G. B., & Fournier, A. E. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2806-05.2006 · Cited by 158
Guest, J. D., Hesse, D. H., Schnell, L., Schwab, M. E., Bunge, M. B., & Bunge, R. P. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19971201)50:5<888::aid-jnr24>3.0.co;2-w · Cited by 156
Modulation of Statin-Activated Shedding of Alzheimer APP Ectodomain by ROCK
Pedrini, S., Carter, T. L., Prendergast, G., Petanceska, S., Ehrlich, M. E., & Gandy, S. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020018 · Cited by 154 · cited 1×
“Inhibition of RhoA/ROCK signaling by statins seems to induce APP cleavage by α-secretase, leading to the reduction of Aβ generation (Pedrini et al., 2005).”
BackgroundMyelin-associated Glycoprotein Inhibits Microtubule Assembly by a Rho-kinase-dependent Mechanism
Mimura, F., Yamagishi, S., Arimura, N., Fujitani, M., Kubo, T., Kaibuchi, K., & Yamashita, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510934200 · Cited by 154
Self-citationPark, J. H., Gimbel, D. A., GrandPré, T., Lee, J.-K., Kim, J., Li, W., Lee, D. H. S., & Strittmatter, S. M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3291-05.2006 · Cited by 152
Rodent models for treatment of spinal cord injury: research trends and progress toward useful repair
Rosenzweig, E. S., & McDonald, J. W. (2004) · Current Opinion in Neurology · doi:10.1097/00019052-200404000-00007 · Cited by 148
The Nogo–Nogo Receptor Pathway Limits a Spectrum of Adult CNS Axonal Growth
Cafferty, W. B. J., & Strittmatter, S. M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3827-06.2006 · Cited by 148
Neuroprotection from Stroke in the Absence of MHCI or PirB
Steinmetz, J. D., Barreto, G. E., Xu, L., Kim, T., Brott, B. K., Ouyang, Y., Naserke, T., Djurisic, M. R., Xiong, X., Shatz, C. J., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.01.020 · Cited by 146
Axonal Protective Effects of the Myelin-Associated Glycoprotein
Nguyen, T. H., Mehta, N. R., Conant, K. E., Kim, K. J., Jones, M., Calabresi, P. A., Melli, G., Höke, A., Schnaar, R. L., Ming, G., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5204-08.2009 · Cited by 142
RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis
Muramatsu, R., Kubo, T., Mori, M., Nakamura, Y., Fujita, Y., Akutsu, T., Okuno, T., Taniguchi, J., Kumanogoh, A., Yoshida, M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2321 · Cited by 131
Self-citationWalters, C. E., Pryce, G., Hankey, D. J. R., Sebti, S. M., Hamilton, A. D., Baker, D., Greenwood, J., & Adamson, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.4087 · Cited by 130
Chivatakarn, O., Kaneko, S., He, Z., Tessier‐Lavigne, M., & Giger, R. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1541-07.2007 · Cited by 127
ROCKing regeneration: Rho kinase inhibition as molecular target for neurorestoration
Tönges, L., Koch, J.-C., Bähr, M., & Lingor, P. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00039 · Cited by 127
Lord-Fontaine, S., Yang, F., Diep, Q. N., Dergham, P., Munzer, J. S., Tremblay, P. J., & McKerracher, L. J. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2008.0613 · Cited by 124
New approaches in the management of multiple sclerosis
Allington, D. R. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s9331 · Cited by 114
A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat
Sung, J.-K., Miao, L., Calvert, J. W., Huang, L., Harkey, H. L., & Zhang, J. H. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03717-4 · Cited by 113
Boato, F., Hendrix, S., Huelsenbeck, S. C., Hofmann, F., Grosse, G., Djalali, S., Klimaschewski, L. P., Auer, M., Just, I., Ahnert‐Hilger, G., et al. (2010) · Journal of Cell Science · doi:10.1242/jcs.066050 · Cited by 110
Expression of the Oligodendrocyte‐Myelin Glycoprotein by Neurons in the Mouse Central Nervous System
Habib, A. A., Marton, L. S., Allwardt, B. A., et al. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041704.x · Cited by 109
Pignot, V., Hein, A. E., Barske, C., Wießner, C., Walmsley, A. R., Kaupmann, K., Mayeur, H., Sommer, B., Mir, A. K., & Frentzel, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01710.x · Cited by 107
Hara, M., Takayasu, M., Watanabe, K., Noda, A., Takagi, T., Suzuki, Y., & Yoshida, J. (2000) · Journal of Neurosurgery Spine · doi:10.3171/spi.2000.93.1.0094 · Cited by 107
Signaling mechanisms of the myelin inhibitors of axon regeneration
Yiu, G. C., & He, Z. (2003) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2003.09.006 · Cited by 105
Tanaka, H., Yamashita, T., Yachi, K., Fujiwara, T., Yoshikawa, H., & Tohyama, M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.010 · Cited by 103
Self-citationActivation of Rho in the injured axons following spinal cord injury
Madura, T., Yamashita, T., Kubo, T., Fujitani, M., Hosokawa, K., & Tohyama, M. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400117 · Cited by 101
Self-citationB cells in MS and NMO: pathogenesis and therapy
Krumbholz, M., & Meinl, E. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0424-x · Cited by 96
Toshima, Y., Satoh, S.-I., Ikegaki, I., & Asano, T. (2000) · Stroke · doi:10.1161/01.str.31.9.2245 · Cited by 93
Unc5B associates with LARG to mediate the action of repulsive guidance molecule
Hata, K., Kaibuchi, K., Inagaki, S., & Yamashita, T. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200807029 · Cited by 92
Self-citationSunico, C. R., Domínguez-Vías, G., García‐Verdugo, J. M., Osta, R., Montero, F., & Moreno‐López, B. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00417.x · Cited by 88
Schwab, J. M., Monnier, P. P., Schluesener, H. J., Conrad, S., Beschorner, R., Chen, L., Meyermann, R., & Mueller, B. K. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1561 · Cited by 86
Sun, X., Minohara, M., Kikuchi, H., Ishizu, T., Tanaka, M., Piao, H. Z., Osoegawa, M., Ohyagi, Y., Shimokawa, H., & Kira, J. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.06.027 · Cited by 80
SAGAWA, H., Terasaki, H., Nakamura, M., Ichikawa, M., Yata, T., TOKITA, Y., & WATANABE, M. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.02.002 · Cited by 80
Nakamura, Y., Fujita, Y., Ueno, M., Takai, T., & Yamashita, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163493 · Cited by 78
Self-citationLaurén, J., Airaksinen, M. S., Saarma, M., & Timmusk, T. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00199-4 · Cited by 78
Myelin suppresses axon regeneration by PIR‐B/SHP‐mediated inhibition of Trk activity
Fujita, Y., Endo, S., Takai, T., & Yamashita, T. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.55 · Cited by 75
Self-citationAre statins a treatment option for multiple sclerosis?
Neuhaus, O., Stüve, O., Zamvil, S. S., & Hartung, H.-P. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00770-7 · Cited by 73
Hu, J. H., Chernoff, K., Pelech, S., & Krieger, C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01669.x · Cited by 72
Omoto, S., Ueno, M., Mochio, S., Takai, T., & Yamashita, T. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3228-10.2010 · Cited by 72
Self-citationNeogenin and repulsive guidance molecule signaling in the central nervous system
Yamashita, T., Mueller, B. K., & Hata, K. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.12.001 · Cited by 71
Self-citationDeyts, C., Galan-Rodriguez, B., Martin, E., Bouveyron, N., Roze, E., Charvin, D., Caboche, J., & Bétuing, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008287 · Cited by 67 · cited 1×
“ROCK inhibitor and ROCK-II siRNA prevent striatal neuronal death induced by polyQ-Huntingtin in vitro (Deyts et al., 2009).”
BackgroundMAG and MOG enhance neurite outgrowth of embryonic mouse spinal cord neurons
Turnley, A. M., & Bartlett, P. F. (1998) · Neuroreport · doi:10.1097/00001756-199806220-00013 · Cited by 66
Myosin IIA is required for neurite outgrowth inhibition produced by repulsive guidance molecule
Kubo, T., Endo, M., Hata, K., Taniguchi, J., Kitajo, K., Tomura, S., Yamaguchi, A., Mueller, B. K., & Yamashita, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05125.x · Cited by 65
Self-citationNakamura, H., Matsuyama, Y., Yoshihara, H., Sakai, Y., Katayama, Y., Nakashima, S., TAKAMATSU, J., & Ishiguro, N. (2005) · Spine · doi:10.1097/01.brs.0000167820.54413.8e · Cited by 64
LINGO-1 Interacts with WNK1 to Regulate Nogo-induced Inhibition of Neurite Extension
Zhang, Z., Xu, X., Zhang, Y., Zhou, J., Yu, Z., & He, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808751200 · Cited by 61
Lesional Expression of RhoA and RhoB following Traumatic Brain Injury in Humans
Brabeck, C., Beschorner, R., Conrad, S., Mittelbronn, M. G. A., Bekure, K., Meyermann, R., Schluesener, H. J., & Schwab, J. M. (2004) · Journal of Neurotrauma · doi:10.1089/0897715041269597 · Cited by 57
Mueller, B. K., Yamashita, T., Schaffar, G., & Mueller, R. (2006) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2006.1888 · Cited by 56
Self-citationHou, S., Liu, C., Li, Y., Yu, J., Feng, L., Liu, Y., Guo, M., Xie, Y., Meng, J., Zhang, H., et al. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12002 · Cited by 49
Interaction between amyloid precursor protein and Nogo receptors regulates amyloid deposition
Zhou, X., Hu, X., He, W., Tang, X., Shi, Q., Zhang, Z., & Yan, R. (2011) · The FASEB Journal · doi:10.1096/fj.11-184325 · Cited by 46
Structure and Function of the Myelin‐Associated Glycoproteinsa
Salzer, J. L., Pedraza, L., BROWN, M., Struyk, A. F., Afar, D., & BELL, J. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb42404.x · Cited by 45
An essential role of MAG in mediating axon–myelin attachment in Charcot–Marie–Tooth 1A disease
Kinter, J., Lazzati, T., Schmid, D., Zeis, T., Erne, B., Lützelschwab, R., Steck, A. J., Pareyson, D., Peles, E., & Schaeren‐Wiemers, N. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.08.009 · Cited by 42
Yu, J., Ding, J., Ma, C., Sun, C., Sun, Y., Lü, C., & Xiao, B. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22339 · Cited by 42
Novotny-Diermayr, V., Lin, B., Gu, L., & Cao, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500175200 · Cited by 40
Fingolimod: A Novel Immunosuppressant for Multiple Sclerosis
Brown, B. A., Kantesaria, P. P., & McDevitt, L. M. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1g424 · Cited by 39
Ishida, T., Takanashi, Y., & Kiwada, H. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.397 · Cited by 38
The Role of Kalirin9 in p75/Nogo Receptor-mediated RhoA Activation in Cerebellar Granule Neurons
Harrington, A., Li, Q. M., Tep, C., Park, J. B., He, Z., & Yoon, S. O. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802188200 · Cited by 37
Developmental Expression of the Oligodendrocyte Myelin Glycoprotein in the Mouse Telencephalon
Gil, V., Bichler, Z., Lee, J. K., Seira, O., Llorens, F., Bribián, A., Morales, R., Claverol-Tinturé, E., Soriano, E., Sumoy, L., et al. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhp246 · Cited by 36
LIM‐only protein 4 interacts directly with the repulsive guidance molecule A receptor Neogenin
Schaffar, G., Taniguchi, J., Brodbeck, T., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05621.x · Cited by 30
Kurihara, Y., Arie, Y., Iketani, M., Ito, H., Nishiyama, K., Sato, Y., Nakamura, F., Mizuki, N., Goshima, Y., & Takei, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.033 · Cited by 22
Disease Modifying Agents for Multiple Sclerosis
Hilas, O., Patel, P. N., & Lam, S. (2010) · The Open Neurology Journal · doi:10.2174/1874205x01004010015 · Cited by 21
Chen, H., Yang, L., Han, M., Bai, S.-G., & Wen, S. (2009) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2009.12.028 · Cited by 19
Jones, M., Nguyen, T. T., Ewaleifoh, O., Lebson, L. A., Whartenby, K. A., Griffin, J. W., & Calabresi, P. A. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.06.008 · Cited by 13
Cited by
ROCK inhibition in models of neurodegeneration and its potential for clinical translation
Koch, J. C., Tatenhorst, L., Roser, A.-E., Saal, K.-A., Tönges, L., & Lingor, P. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.008 · Cited by 239
RhoA-ROCK Signaling as a Therapeutic Target in Traumatic Brain Injury
Mulherkar, S., & Tolias, K. F. (2020) · Cells · doi:10.3390/cells9010245 · Cited by 179
p120-catenin-dependent collective brain infiltration by glioma cell networks
Gritsenko, P. G., Atlasy, N., Dieteren, C. E. J., Navis, A. C., Venhuizen, J.-H., Veelken, C., Schubert, D., Acker-Palmer, A., Westerman, B. A., Wurdinger, T., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-019-0443-x · Cited by 112
Zhao, H., Zhang, X., Dai, Z., Feng, Y., Li, Q., Zhang, J. H., Liu, X., Chen, Y., & Feng, H. (2016) · Scientific Reports · doi:10.1038/srep23286 · Cited by 84
“RhoA is a small guanosine triphosphate-binding protein known to regulate the formation of focal adhesions and stress fibers in response to growth factors 36 .”
Role of P2X7 Receptors in Immune Responses During Neurodegeneration
Oliveira-Giacomelli, Á., Petiz, L. L., Andrejew, R., Turrini, N., Silva, J. B., Sack, U., & Ulrich, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.662935 · Cited by 68
Metadata
- Authors
- Fujita, Y., & Yamashita, T.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2014-10-22
- Volume
- 8
- Pages
- 338-338
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2073900221
- Cited by
- 269
- References
- 172
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.